Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Debt to Equity Ratio : 0.1335 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1335 |
| March 31, 2026 | 0.1253 |
| December 31, 2025 | 0.1168 |
| September 30, 2025 | 0.1157 |
| June 30, 2025 | 0.1167 |
| March 31, 2025 | 0.1825 |
| December 31, 2024 | 0.1185 |
| September 30, 2024 | 0.1124 |
| June 30, 2024 | 0.1194 |
| March 31, 2024 | 0.1209 |
| December 31, 2023 | 0.1085 |
| September 30, 2023 | 0.1829 |
| June 30, 2023 | 0.1129 |
| March 31, 2023 | 0.1008 |
| December 31, 2022 | 0.3505 |
| September 30, 2022 | 0.6504 |
| June 30, 2022 | 0.5764 |
| March 31, 2022 | 0.3746 |
| December 31, 2021 | 0.2963 |
| September 30, 2021 | 0.2595 |
| June 30, 2021 | 0.2228 |
| March 31, 2021 | 0.1941 |
| December 31, 2020 | 0.0523 |
| September 30, 2020 | 0.0781 |
| June 30, 2020 | 0.2225 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.244 |
| December 31, 2019 | 0.8015 |
| September 30, 2019 | 0.4425 |
| June 30, 2019 | 0.7416 |
| March 31, 2019 | 2.546 |
| December 31, 2018 | 0.7265 |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Exelixis, Inc. | 0.09 |
| PTC Therapeutics, Inc. | -4.212 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 224.31M |
| Total Liabilities (Quarterly) | 52.50M |
| Shareholders Equity (Quarterly) | 171.81M |
| Current Ratio | 5.879 |
| Net Debt Paydown Yield | 2.07% |